跳至主要内容
临床试验/ACTRN12617001011370
ACTRN12617001011370招募中不适用

Diagnostic accuracy of fine needle aspiration (FNA) with 22G EchoTip needle and rapid on-site evaluation (ROSE) versus fine needle biopsy (FNB) with 22G ProCore needle and without ROSE for EUS guided tissue acquisition of pancreatic masses: a multi-centre randomized control trial.

Royal Adelaide Hospital0 个研究点目标入组 598 人开始时间: 2017年7月14日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
598

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Diagnosis

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Aged 18 years old or over
  • 2. Patients requiring endoscopic ultrasound and tissue sampling of solid lesions greater than 1cm diameter in the pancreas that are visualized and within the reach of EUS FNA.

排除标准

  • 1. Pregnant females
  • 2. Uncorrectable coagulation disorder (INR > 1.5)
  • 3. Those with medical co-morbidities that preclude them from sedation (as determined by anaesthetic team)
  • 4. Actively on medications that increase the risk of bleeding from EUS guided tissue acquisition (NOAC, warfarin, combined aspirin and clopidogrel)
  • 5. Those unable to give informed consent

研究者

相似试验